Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

[ad_1] The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. [ad_2] Source link

Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges

[ad_1] Boxes of tablets produced by Teva Pharmaceutical Industries. Chris Ratcliffe | Bloomberg | Getty Images Drugmaker Teva Pharmaceuticals agreed to pay $225 million in criminal fines over five years…

Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It

[ad_1] Health Teva, Allergan, CVS and Walgreens say enough states agreed to final agreements, adding to the billions flowing to communities [ad_2] Source link

Nexgen Pharma, Inc., Teva Pharmaceutical Industries Ltd., Wraser Pharmaceuticals LLC

[ad_1]

Upcoming Opportunities in Healthcare Nanotechnology (Nanomedicine) Market Business Strategies, Current Insights, Regional Developments, Demand and Forecast to 2030Amgen, Teva Pharmaceuticals, Abbott

[ad_1] Contact Us: Stratagem Market Insights UK: +44-203-289-4040 Email: [email protected]